Inclusion of Polypills for Prevention of Cardiovascular Disease in the 23rd World Health Organization Model List of Essential Medicines: A Significant Step Towards Reducing Global Cardiovascular Morbidity and Mortality
This commentary describes the potential impact of inclusion of polypills for prevention of cardiovascular disease in the 23rd WHO Model List of Essential Medicines, and provides a roadmap for adoption, implementation, sustainment, and scale-up. The World Health Organization's endorsement of pol...
Saved in:
Main Authors: | Anubha Agarwal (Author), Mark D. Huffman (Author) |
---|---|
Format: | Book |
Published: |
Ubiquity Press,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality
by: Ezequiel J. Zaidel, et al.
Published: (2020) -
The Concept of the Polypill in the Prevention of Cardiovascular Disease
by: Brandon Wiley, et al.
Published: (2014) -
A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
by: Gautam Satheesh, et al.
Published: (2024) -
Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
by: Gautam Satheesh, et al.
Published: (2024) -
Redefining the polypill: pros and cons in cardiovascular precision medicine
by: Siddharth Birla, et al.
Published: (2023)